세계의 하이드로콜로이드 드레싱 시장 : 세계 및 지역별 분석 - 지역별, 국가별 분석, 경쟁 구도, 분석과 예측(2023년-2030년)

Global Hydrocolloid Dressings Market Industry Overview

The global hydrocolloid dressings market, which was valued at $792.8 million in 2022, has been experiencing robust growth and is projected to reach $1,029.9 million by 2030. This dynamic market is expected to expand at a compound annual growth rate (CAGR) of 3.37% between 2023 and 2030, driven by increasing demand across various healthcare settings. Hydrocolloid dressings are favored in clinical and home care environments for their effectiveness in managing wounds by maintaining a moist healing environment, which is crucial for promoting faster healing and reducing the risk of infection. These dressings are particularly beneficial for treating chronic wounds, such as diabetic ulcers, venous ulcers, and pressure sores, which are prevalent in the aging population.

Market Introduction

The growth of the hydrocolloid dressings market is fueled by advancements in material science and product innovation aimed at improving patient comfort and dressing performance. As healthcare providers continue to seek out more efficient and effective wound care solutions, the demand for hydrocolloid dressings is expected to rise. Additionally, the increasing prevalence of diabetes and other chronic diseases worldwide contributes to the growing need for advanced wound care products. The market's expansion is also supported by a rising emphasis on cost-effective treatment options and the shift towards home healthcare, which aligns with the growing trend of patient-centered care. These factors collectively underscore the vital role of hydrocolloid dressings in modern healthcare and their continued impact on the industry's future landscape.

Regional Segmentation:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Russian Federation
  • Turkey
  • Poland
  • Belgium
  • Sweden
  • Ireland
  • Norway
  • Austria
  • Denmark
  • Finland
  • Portugal
  • Czech Republic
  • Romania
  • Greece
  • Slovakia
  • Ukraine
• Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Malaysia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Colombia
  • Argentina
  • Chile
• Rest-of-the-World

The global hydrocolloid dressings market is experiencing steady growth across various regions, with a total market valuation expected to increase from $792.8 million in 2022 to $1,029.9 million by 2030, at a CAGR of 3.37%. In this diverse market landscape, Asia-Pacific and Latin America have emerged as regions with the highest growth rates, at 4.26% and 4.40%, respectively, driven by increasing healthcare infrastructure improvements and growing awareness of advanced wound care. Europe and North America also show significant growth, with CAGRs of 2.56% and 2.91%, reflecting well-established healthcare systems and a high prevalence of chronic conditions that require ongoing wound care management. The Rest-of-the-World region, including parts of Africa and other underserved markets, is projected to experience the fastest growth rate at 5.04%, indicating an expanding recognition of and demand for hydrocolloid dressing solutions in these areas. Collectively, these regional trends highlight the increasing global reliance on hydrocolloid dressings for effective wound management solutions in both developed and developing markets.

How can this report add value to the organization?

Product/Innovation Strategy: Understanding specific regional needs and preferences can guide companies in customizing or developing new products that cater specifically to local market demands, such as dressings adapted to varying climate conditions or skin types prevalent in certain areas.

Growth/Marketing Strategy: By understanding which regions hold the largest market size or fastest growth rates, companies can strategically plan their expansion or increase their market activities in those areas to maximize return on investment (ROI).

Competitive Strategy: Understanding who the local competitors are, their market share, and their strategic moves can help a company position its products more effectively. This could involve highlighting unique product features that competitors lack or matching price points.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

• The base year considered for the calculation of the market size is 2022. A historical year analysis has been done for the period FY2019-FY2021. The market size has been estimated for FY2022 and projected for the period FY2023-FY2030.
• The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of upstream and downstream products of hydrocolloid dressings.
• The market contribution of hydrocolloid dressings anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
• Revenues of the companies have been referenced from their annual reports for FY2022 and FY2023. For private companies, revenues have been estimated based on factors such as inputs obtained from primary research, funding history, market collaborations, and operational history.
• The market has been mapped based on the available hydrocolloid dressings solutions. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in hydrocolloid dressings, including the market players offering products and services. Resources such as CEOs, vice presidents, marketing directors, and salespersons have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

• Validation and triangulation of all the numbers and graphs
• Validation of the report's segmentation and key qualitative findings
• Understanding the competitive landscape and business model
• Current and proposed production values of a product by market players
• Percentage split of individual markets for regional analysis

Secondary Research

Open Sources

• Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
• Annual reports, SEC filings, and investor presentations of the leading market players
• Company websites and detailed study of their product portfolio
• Gold standard magazines, journals, white papers, press releases, and news articles
• Paid databases

The key data points taken from the secondary sources include:

• Segmentations and percentage shares
• Data for market value
• Key industry trends of the top players of the market
• Qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
• Quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

In the dynamic landscape of hydrocolloid dressings, Avery Dennison Corporation, ConvaTec, and Coloplast emerge as key players with diverse product portfolios aimed at addressing varying wound care needs. Avery Dennison Belgie, Bvba offers a range including standard and bordered hydrocolloid wound dressings, as well as MED 5556H, catering to specific requirements. ConvaTec presents hydrocolloid dressings in different sizes and formats, such as thin dressings and paste tubes, demonstrating versatility. Meanwhile, Coloplast showcases its expertise with offerings like hydrocolloid dressings in various dimensions and the innovative Comfeel Plus Dressing. This competitive arena underscores a commitment to innovation and customization, driving advancements in wound management solutions.

Some of the prominent companies in this market are:

• Avery Dennison Corporation
• ConvaTec
• Coloplast
• Cardinal Health
• 3M
• Bimedica
• McKesson Medical Surgical Inc,
• L&R Group
• Gentall
• Medline Industries
• Acto GmbH

Table of Contents

Executive Summary

1 Markets

• 1.1 Product Definition
• 1.2 Inclusion and Exclusion Criteria
  • 1.2.1 Inclusion
  • 1.2.2 Exclusion Criteria
• 1.3 Key Questions Answered
• 1.4 Analysis and Forecast Note
• 1.5 Key Findings

2 Regions

• 2.1 Regional Summary
• 2.2 North America
  • 2.2.1 U.S.
  • 2.2.2 Canada
• 2.3 Europe
  • 2.3.1 Germany
  • 2.3.2 Austria
  • 2.3.3 Czech Republic
  • 2.3.4 Greece
  • 2.3.5 Poland
  • 2.3.6 Romania
  • 2.3.7 Russian Federation
  • 2.3.8 Slovakia
  • 2.3.9 Turkey
  • 2.3.10 Ukraine
  • 2.3.11 Belgium
  • 2.3.12 Denmark
  • 2.3.13 Finland
  • 2.3.14 France
  • 2.3.15 Ireland
  • 2.3.16 Italy
  • 2.3.17 Netherlands
  • 2.3.18 Norway
  • 2.3.19 Portugal
  • 2.3.20 Spain
  • 2.3.21 Sweden
  • 2.3.22 Switzerland
  • 2.3.23 U.K.
• 2.4 Asia-Pacific
  • 2.4.1 Australia
  • 2.4.2 China
  • 2.4.3 India
  • 2.4.4 Japan
  • 2.4.5 Malaysia
  • 2.4.6 South Korea
  • 2.4.7 Thailand
• 2.5 Latin America
  • 2.5.1 Argentina
  • 2.5.2 Brazil
  • 2.5.3 Chile
  • 2.5.4 Colombia
  • 2.5.5 Mexico
• 2.6 Rest-of-the-World

3 Markets - Competitive Benchmarking

• 3.1 Key Companies Ecosystem

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast